Literature DB >> 17454167

Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone.

Claudia Kohler1, Katharina Tschumi, Christine Bodmer, Martin Schneiter, Martin Birkhaeuser.   

Abstract

BACKGROUND: In some women with acne or alopecia who have normal serum levels of free testosterone, no clinical improvement can be reached by the classical treatment with antiandrogens, isotretinoids or corticosteroids. Our hypothesis is that some of these women have an excessive activity of the enzyme 5alpha-reductase.
OBJECTIVE: To evaluate the subjective benefit of the treatment with finasteride (5 mg/day) in women with normal serum levels of free testosterone suffering from acne or alopecia.
DESIGN: This was a retrospective study evaluating a questionnaire filled out by 12 patients, six of whom had acne and six of whom had alopecia.
RESULTS: Nine of the 12 patients benefited from the treatment, their symptoms decreased significantly and they felt better psychologically than before the administration of finasteride. The other three patients did not benefit at all from finasteride and reported no change in the extent of the acne/alopecia. Treatment was generally well tolerated, only a few adverse effects were noted.
CONCLUSIONS: Nine of the 12 patients benefited from the treatment. This supports our hypothesis of an excessive activity of 5alpha-reductase enzyme in peripheral tissue in these patients. The fact that three of the patients did not realize any change in their symptom severity implies that there must also be other pathways in the genesis of acne and alopecia in women with normal levels of free testosterone. Further evaluation is needed to elucidate more precise indications for the administration of finasteride in women with acne and alopecia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454167     DOI: 10.1080/09513590701214463

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  10 in total

Review 1.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 2.  Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.

Authors:  Jason M Hirshburg; Petra A Kelsey; Chelsea A Therrien; A Carlo Gavino; Jason S Reichenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

Review 3.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

4.  Profiling and hormonal therapy for acne in women.

Authors:  Sangita Ghosh; Soumik Chaudhuri; Vijay Kumar Jain; Kamal Aggarwal
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

Review 5.  Female pattern hair loss.

Authors:  Ingrid Herskovitz; Antonella Tosti
Journal:  Int J Endocrinol Metab       Date:  2013-10-21

6.  Adverse Effects with Finasteride 5 mg/day for Patterned Hair Loss in Premenopausal Women.

Authors:  Rui Oliveira-Soares; Marisa C André; Miguel Peres-Correia
Journal:  Int J Trichology       Date:  2018 Jan-Feb

Review 7.  Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

Authors:  Alison M Layton; E Anne Eady; Heather Whitehouse; James Q Del Rosso; Zbys Fedorowicz; Esther J van Zuuren
Journal:  Am J Clin Dermatol       Date:  2017-04       Impact factor: 7.403

Review 8.  The epidemiology of acne vulgaris in late adolescence.

Authors:  Darren D Lynn; Tamara Umari; Cory A Dunnick; Robert P Dellavalle
Journal:  Adolesc Health Med Ther       Date:  2016-01-19

9.  Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population.

Authors:  Xue Hu; Wei Ding; Xinye Jin; Jia Wang; Dajin Zou; Yue Chen
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

Review 10.  Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.

Authors:  Wimolsiri Iamsumang; Kanchana Leerunyakul; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2020-03-02       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.